About Healx
Healx is a company based in Cambridge (United Kingdom) founded in 2014 by David Brown, Tim Guilliams, and Nick Sireau.. Healx has raised $115.37 million across 6 funding rounds from investors including Atomico, Balderton Capital and R42 Group. The company has 80 employees as of December 31, 2021. Healx offers products and services including AI Drug Discovery Platform and Drug Pipeline. Healx operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others.
- Headquarter Cambridge, United Kingdom
- Employees 80 as on 31 Dec, 2021
- Founders David Brown, Tim Guilliams, Nick Sireau
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Healx Limited
- Date of Incorporation 30 Apr, 2014
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
$412.68 (USD)0as on Dec 31, 2021
-
Net Profit
$-21.57 K (USD)-95as on Dec 31, 2021
-
EBITDA
-
Total Equity Funding
$115.37 M (USD)
in 6 rounds
-
Latest Funding Round
$47 M (USD), Series C
Aug 01, 2024
-
Investors
Atomico
& 11 more
-
Employee Count
80
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Healx
Healx offers a comprehensive portfolio of products and services, including AI Drug Discovery Platform and Drug Pipeline. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Uses AI to identify and repurpose compounds for rare disease treatments
Manages programs for developing new therapies for rare diseases
Unlock access to complete
Unlock access to complete
Funding Insights of Healx
Healx has successfully raised a total of $115.37M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $47 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $47.0M
-
First Round
First Round
(15 Apr 2015)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series C - Healx | Valuation | Atomico , R42 Group | |
| Jun, 2022 | Amount | Series C - Healx | Valuation | AYANA |
|
| Oct, 2019 | Amount | Series B - Healx | Valuation | Atomico |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Healx
Healx has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Atomico, Balderton Capital and R42 Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech-based companies are invested in by Atomico venture capital fund.
|
Founded Year | Domain | Location | |
|
Tech startups are funded by R42 Group venture capital.
|
Founded Year | Domain | Location | |
|
Multistage venture capital investments are focused on technology sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Healx
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Healx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Healx Comparisons
Competitors of Healx
Healx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Rhythm Pharmaceuticals and Horizon Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Healx
Frequently Asked Questions about Healx
When was Healx founded?
Healx was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Healx located?
Healx is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Who is the current CEO of Healx?
Tim Guilliams is the current CEO of Healx. They have also founded this company.
Is Healx a funded company?
Healx is a funded company, having raised a total of $115.37M across 6 funding rounds to date. The company's 1st funding round was a Series B of $56M, raised on Apr 15, 2015.
How many employees does Healx have?
As of Dec 31, 2021, the latest employee count at Healx is 80.
What is the annual revenue of Healx?
Annual revenue of Healx is $412.68 as on Dec 31, 2021.
What does Healx do?
Healx was founded in 2014 in Cambridge, United Kingdom, and operates in the biotechnology sector. An AI-driven platform is utilized to identify treatments for rare diseases, with a pipeline targeting conditions such as Fragile X syndrome, autosomal dominant polycystic kidney disease, chronic pancreatitis, and facioscapulohumeral muscular dystrophy. Operations focus on advancing novel drug candidates through computational methods and clinical development.
Who are the top competitors of Healx?
Healx's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Healx offer?
Healx offers AI Drug Discovery Platform and Drug Pipeline.
Who are Healx's investors?
Healx has 12 investors. Key investors include Atomico, Balderton Capital, R42 Group, BtoV, and Global Brain.